Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2546468rdf:typepubmed:Citationlld:pubmed
pubmed-article:2546468lifeskim:mentionsumls-concept:C1282910lld:lifeskim
pubmed-article:2546468lifeskim:mentionsumls-concept:C0458827lld:lifeskim
pubmed-article:2546468lifeskim:mentionsumls-concept:C1291081lld:lifeskim
pubmed-article:2546468lifeskim:mentionsumls-concept:C0032172lld:lifeskim
pubmed-article:2546468lifeskim:mentionsumls-concept:C0597750lld:lifeskim
pubmed-article:2546468lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:2546468lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:2546468pubmed:issue1lld:pubmed
pubmed-article:2546468pubmed:dateCreated1989-8-11lld:pubmed
pubmed-article:2546468pubmed:abstractTextLyso-PAF-acether and PAF-acether (formerly platelet-activating factor) were detected in nasal secretions from patients with hay fever who underwent local antigen challenge. Lyso-PAF release was observed in 12 of 13 patients, with a maximum (p less than 0.001) 5 min after stimulation and a progressive decrease during the first hour. PAF was detected in the 5-min postchallenge nasal washings from two of 13 subjects. After HPLC, this mediator was found in four of seven postchallenge nasal washings submitted to this procedure, with a peak 5 min and 10 min after provocation. Histamine analysis revealed a significant (p less than 0.001) but time-limited (5 min) release in nasal secretion. The pattern of immunoreactive leukotriene C4 showed a maximal peak (p less than 0.01) 5 min after allergen provocation, with raised levels for 20 min. Nasal stimulation with nebulized saline solution or grass pollens in healthy subjects and in patients suffering from allergic rhinitis caused by Dermatophagoides pteronyssinus was followed by no local mediator release. These data indicate that, in addition to histamine and peptide-leukotrienes, lyso-PAF and PAF are released in nasal secretions after local antigen stimulation in patients with hay fever, with a preponderance of lyso-PAF response. On the basis of these results, it is conceivable that these ether-phospholipids may be involved in allergic inflammation of human nasal airways.lld:pubmed
pubmed-article:2546468pubmed:languageenglld:pubmed
pubmed-article:2546468pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2546468pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2546468pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2546468pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2546468pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2546468pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2546468pubmed:statusMEDLINElld:pubmed
pubmed-article:2546468pubmed:monthJullld:pubmed
pubmed-article:2546468pubmed:issn0003-0805lld:pubmed
pubmed-article:2546468pubmed:authorpubmed-author:BenvenisteJJlld:pubmed
pubmed-article:2546468pubmed:authorpubmed-author:ZanussiCClld:pubmed
pubmed-article:2546468pubmed:authorpubmed-author:ArnouxBBlld:pubmed
pubmed-article:2546468pubmed:authorpubmed-author:SalaAAlld:pubmed
pubmed-article:2546468pubmed:authorpubmed-author:MiadonnaAAlld:pubmed
pubmed-article:2546468pubmed:authorpubmed-author:TedeschiAAlld:pubmed
pubmed-article:2546468pubmed:issnTypePrintlld:pubmed
pubmed-article:2546468pubmed:volume140lld:pubmed
pubmed-article:2546468pubmed:ownerNLMlld:pubmed
pubmed-article:2546468pubmed:authorsCompleteYlld:pubmed
pubmed-article:2546468pubmed:pagination142-7lld:pubmed
pubmed-article:2546468pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:2546468pubmed:meshHeadingpubmed-meshheading:2546468-...lld:pubmed
pubmed-article:2546468pubmed:meshHeadingpubmed-meshheading:2546468-...lld:pubmed
pubmed-article:2546468pubmed:meshHeadingpubmed-meshheading:2546468-...lld:pubmed
pubmed-article:2546468pubmed:meshHeadingpubmed-meshheading:2546468-...lld:pubmed
pubmed-article:2546468pubmed:meshHeadingpubmed-meshheading:2546468-...lld:pubmed
pubmed-article:2546468pubmed:meshHeadingpubmed-meshheading:2546468-...lld:pubmed
pubmed-article:2546468pubmed:meshHeadingpubmed-meshheading:2546468-...lld:pubmed
pubmed-article:2546468pubmed:meshHeadingpubmed-meshheading:2546468-...lld:pubmed
pubmed-article:2546468pubmed:meshHeadingpubmed-meshheading:2546468-...lld:pubmed
pubmed-article:2546468pubmed:meshHeadingpubmed-meshheading:2546468-...lld:pubmed
pubmed-article:2546468pubmed:meshHeadingpubmed-meshheading:2546468-...lld:pubmed
pubmed-article:2546468pubmed:meshHeadingpubmed-meshheading:2546468-...lld:pubmed
pubmed-article:2546468pubmed:meshHeadingpubmed-meshheading:2546468-...lld:pubmed
pubmed-article:2546468pubmed:meshHeadingpubmed-meshheading:2546468-...lld:pubmed
pubmed-article:2546468pubmed:meshHeadingpubmed-meshheading:2546468-...lld:pubmed
pubmed-article:2546468pubmed:year1989lld:pubmed
pubmed-article:2546468pubmed:articleTitleEvidence of PAF-acether metabolic pathway activation in antigen challenge of upper respiratory airways.lld:pubmed
pubmed-article:2546468pubmed:affiliationDepartment of Internal Medicine, Infectious Diseases and Immunopathology, University of Milan, Ospedale Maggiore Policlinico, Italy.lld:pubmed
pubmed-article:2546468pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2546468lld:pubmed